We report a third-generation sequencing assay on nanopore technology (MinION) for detecting BCR-ABL1 KD mutations and compare the results to a Sanger sequencing(SS)-based test in 24 Philadelphia-positive (Ph +) leukemia cases. Our data indicates that MinION is markedly superior to SS in terms of sensitivity, costs and timesaving, and has the added advantage of determining the clonal configuration of multiple mutations. We demonstrate that MinION is suitable for employment in the hematology laboratory for detecting BCR-ABL1 KD mutation in Ph + leukemias.
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology
Minervini, Crescenzio F.;Cumbo, Cosimo;Orsini, Paola;Anelli, Luisa;Zagaria, Antonella;Impera, Luciana;Coccaro, Nicoletta;Brunetti, Claudia;Minervini, Angela;Casieri, Paola;Tota, Giuseppina;Specchia, Giorgina;Albano, Francesco
2017-01-01
Abstract
We report a third-generation sequencing assay on nanopore technology (MinION) for detecting BCR-ABL1 KD mutations and compare the results to a Sanger sequencing(SS)-based test in 24 Philadelphia-positive (Ph +) leukemia cases. Our data indicates that MinION is markedly superior to SS in terms of sensitivity, costs and timesaving, and has the added advantage of determining the clonal configuration of multiple mutations. We demonstrate that MinION is suitable for employment in the hematology laboratory for detecting BCR-ABL1 KD mutation in Ph + leukemias.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology.pdf
non disponibili
Tipologia:
Documento in Versione Editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
548.82 kB
Formato
Adobe PDF
|
548.82 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.